Thereinto, the incidence of esophageal squamous cell carcinoma, esophagogastric adenocarcinoma, and CHOL is the highest, which suggests that we should pay attention to the relationship between GPC2 gene mutation and digestive system tumors. This evidence concerns the gene GPC2 and gastroesophageal junction adenocarcinoma.